ROLE OF MACROPHAGE RECEPTORS FOR OXLDL IN ATHEROGENESIS
ROLE OF MACROPHAGE RECEPTORS FOR OXLDL IN ATHEROGENESIS
批准号:
6242770
负责人:
DANIEL STEINBERG
金额:
$13.41万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-04-23 至 1998-03-31
关键词:
CD antigens Xenopus oocyte atherosclerotic plaque binding proteins blood lipoprotein chimeric proteins gene targeting human subject in situ hybridization laboratory mouse low density lipoprotein receptor macrophage molecular cloning molecular pathology phlebotomy receptor binding thrombospondins transfection vitronectin
中文摘要
拟议研究的长期目标是改善我们的
了解脂蛋白-巨噬细胞相互作用,
有助于泡沫细胞形成和动脉粥样硬化形成。 重点将
将其置于乙酰LDL受体(SRA)、hCD 36及其小鼠上,
同源物(mDC 36)和94-97 kDa氧化LDL(OxLDL)-
小鼠腹腔巨噬细胞的结合蛋白,
以前被表征,现在被鉴定为macrosialin。
Macrosialin及其人类同源物DC 68,之前都是
克隆,主要存在于晚期内体部分,
其功能尚不清楚。 我们建议研究它们的运输
在亚细胞区室之间,以制备稳定转染的细胞
为了表征它们的配体结合特性,鉴定配体
通过制备嵌合蛋白和通过位点-
定向诱变,并制备麦胡萝卜素敲除小鼠,
确定巨噬细胞的表型结果
功能、免疫功能和动脉粥样硬化形成。 CD 36是一种
OxLDL结合受体,在结合和吞噬中起作用
与玻连蛋白受体合作,
血小板反应蛋白 我们将检验一个假设,
氧化低密度脂蛋白可以通过这种相互作用来调节。 使用细胞
来自SRA敲除小鼠(T.儿玉),我们将
评估受体在体外和体内OxLDL代谢中的作用,
vivo. 最后,我们将继续使用表达克隆,
非洲爪蟾卵母细胞寻找额外的巨噬细胞蛋白,
可能参与摄取OxLDL或/和受损或
凋亡细胞已经分离出五个克隆体。 没有一
它们代表SRA、mCD 36或巨唾液酸蛋白。 这些将
进行测序和鉴定。
英文摘要
The long term goal of the proposed studies is to improve our
understanding of lipoprotein-macrophage interactions that may
contribute to foam cell formation and atherogenesis. Emphasis will
be placed on the acetyl LDL receptor (SRA), hCD36 and its mouse
homologue (mDC36), and a 94-97 kDa oxidized LDL (OxLDL)-
binding protein from mouse peritoneal macrophages which we have
previously characterized and have now identified as macrosialin.
Macrosialin and its human homologue, DC68, both previously
clones, are found predominantly in the late endosomal fraction and
their functions are not known. We propose to study their transport
between subcellular compartment, to prepare stably transfected cells
to characterize their ligand-binding properties, identify ligand
binding sites by preparation of chimeric proteins and by site-
directed mutagenesis, and prepare a mcarosialin knockout mouse to
ascertain phenotypic consequences with regard to macrophage
function, immune function and atherogenesis. CD36, an established
OxLDL-binding receptor, functions in the binding and phagocytosis
of apoptotic cells in cooperation with the vitronectin receptor and
thrombospondin. We will test the hypothesis that binding of
OxLDL may be modulated by interactions of this kind. Using cells
from the SRA knockout mouse (gift of Dr. T. Kodama), we will
assess the role of the receptor in OxLDL metabolism in vitro and in
vivo. Finally, we will continue to use expression cloning in
Xenopus oocytes to search for additional macrophage proteins that
may participate in uptake of OxLDL or/and of damaged or
apoptotic cells. Five clones have already been isolated. None of
them represents either SRA, mCD36, or macrosialin. These will
be sequenced and characterized.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ROLE OF MACROPHAGE RECEPTORS FOR OXLDL IN ATHEROGENESIS
-
批准号:6450713
-
项目类别:
-
资助金额:$27.43万
-
财政年份:2001
-
负责人:DANIEL STEINBERG
-
依托单位:
ROLE OF MACROPHAGE RECEPTORS FOR OXLDL IN ATHEROGENESIS
-
批准号:6302476
-
项目类别:
-
资助金额:$18.58万
-
财政年份:2000
-
负责人:DANIEL STEINBERG
-
依托单位:
ROLE OF MACROPHAGE RECEPTORS FOR OXLDL IN ATHEROGENESIS
-
批准号:6110776
-
项目类别:
-
资助金额:$18.58万
-
财政年份:1999
-
负责人:DANIEL STEINBERG
-
依托单位:
ROLE OF MACROPHAGE RECEPTORS FOR OXLDL IN ATHEROGENESIS
-
批准号:6273232
-
项目类别:
-
资助金额:$18.08万
-
财政年份:1998
-
负责人:DANIEL STEINBERG
-
依托单位:
LIPIDS, LIPOPROTEINS AND ATHEROSCLEROSIS
-
批准号:2212185
-
项目类别:
-
资助金额:$11.59万
-
财政年份:1994
-
负责人:DANIEL STEINBERG
-
依托单位:
LIPIDS, LIPOPROTEINS AND ATHEROSCLEROSIS
-
批准号:2212187
-
项目类别:
-
资助金额:$11.57万
-
财政年份:1994
-
负责人:DANIEL STEINBERG
-
依托单位:
LIPIDS, LIPOPROTEINS AND ATHEROSCLEROSIS
-
批准号:2637547
-
项目类别:
-
资助金额:$8.89万
-
财政年份:1994
-
负责人:DANIEL STEINBERG
-
依托单位:
LIPIDS, LIPOPROTEINS AND ATHEROSCLEROSIS
-
批准号:2212186
-
项目类别:
-
资助金额:$11.19万
-
财政年份:1994
-
负责人:DANIEL STEINBERG
-
依托单位:
LIPIDS, LIPOPROTEINS AND ATHEROSCLEROSIS
-
批准号:2027290
-
项目类别:
-
资助金额:$11.49万
-
财政年份:1994
-
负责人:DANIEL STEINBERG
-
依托单位:
ASPEN BILE ACID/CHOLESTEROL/LIPOPROTEIN CONFERENCE
-
批准号:3435706
-
项目类别:
-
资助金额:$0.5万
-
财政年份:1991
-
负责人:DANIEL STEINBERG
-
依托单位:
PROGRAM PHYSICIAN SCIENTIST AWARD
-
批准号:2328406
-
项目类别:
-
资助金额:$16.38万
-
财政年份:1990
-
负责人:DANIEL STEINBERG
-
依托单位:
PHYSICIAN SCIENTIST PROGRAM AWARD
-
批准号:3088160
-
项目类别:
-
资助金额:$36.14万
-
财政年份:1990
-
负责人:DANIEL STEINBERG
-
依托单位:
PROGRAM PHYSICIAN SCIENTIST AWARD
-
批准号:2133526
-
项目类别:
-
资助金额:$41.7万
-
财政年份:1990
-
负责人:DANIEL STEINBERG
-
依托单位:
PROGRAM PHYSICIAN SCIENTIST AWARD
-
批准号:3088166
-
项目类别:
-
资助金额:$15.26万
-
财政年份:1990
-
负责人:DANIEL STEINBERG
-
依托单位:
PROGRAM PHYSICIAN SCIENTIST AWARD
-
批准号:2133525
-
项目类别:
-
资助金额:$38.42万
-
财政年份:1990
-
负责人:DANIEL STEINBERG
-
依托单位:
PROGRAM PHYSICIAN SCIENTIST AWARD
-
批准号:3088167
-
项目类别:
-
资助金额:$34.65万
-
财政年份:1990
-
负责人:DANIEL STEINBERG
-
依托单位:
PROGRAM PHYSICIAN SCIENTIST AWARD
-
批准号:3088165
-
项目类别:
-
资助金额:$38.96万
-
财政年份:1990
-
负责人:DANIEL STEINBERG
-
依托单位:
PROGRAM PHYSICIAN SCIENTIST AWARD
-
批准号:2616175
-
项目类别:
-
资助金额:$8.52万
-
财政年份:1990
-
负责人:DANIEL STEINBERG
-
依托单位:
PHYSICIAN SCIENTIST PROGRAM AWARD
-
批准号:3088162
-
项目类别:
-
资助金额:$28.6万
-
财政年份:1985
-
负责人:DANIEL STEINBERG
-
依托单位:
PHYSICIAN SCIENTIST PROGRAM AWARD
-
批准号:3088064
-
项目类别:
-
资助金额:$12.92万
-
财政年份:1985
-
负责人:DANIEL STEINBERG
-
依托单位:
海外基金